Vitamin B1 (Thiamine Mononitrate) Market Overview
Global Vitamin B1 (Thiamine Mononitrate) Market size is projected at USD 825.22 million in 2024 and is anticipated to reach USD 1247.64 million by 2033, registering a CAGR of 4.7%.
The global Vitamin B1 (Thiamine Mononitrate) market has experienced notable growth, driven by increasing awareness of its health benefits and expanding applications across various industries. In 2024, the market was valued at approximately USD 747.56 million and is projected to reach USD 1.39 billion by 2037 . This growth is attributed to the rising prevalence of vitamin B1 deficiencies, particularly among the elderly and individuals with specific medical conditions.
Thiamine mononitrate, a stable form of Vitamin B1, is widely utilized in dietary supplements, fortified foods, and pharmaceuticals. The Asia Pacific region holds a significant share of the market, accounting for about 38.8% in 2021, due to its robust pharmaceutical and nutraceutical industries . Product forms such as tablets and capsules dominate the market, comprising approximately 60% of the total share in 2023 .
Key Findings
Top Driver Reason: Increasing consumer awareness of the health benefits of Vitamin B1.
Top Country/Region: Asia Pacific, with a market share of 38.8% in 2021.
Top Segment: Tablets and capsules, comprising 60% of the market share in 2023.
Vitamin B1 (Thiamine Mononitrate) Market Trends
The Vitamin B1 (Thiamine Mononitrate) market is witnessing several key trends that are shaping its growth trajectory. One prominent trend is the increasing demand for fortified foods and dietary supplements. Consumers are becoming more health-conscious, leading to a surge in the consumption of products enriched with essential vitamins, including Vitamin B1. This shift is particularly evident in regions with aging populations, where the need for nutritional supplementation is more pronounced.
Another significant trend is the growing preference for sustainable and bio-based sources of Vitamin B1. Manufacturers are exploring renewable resources such as corn starch and cellulose to produce thiamine mononitrate, aligning with the global push towards environmentally friendly and sustainable production practices. This move not only caters to the eco-conscious consumer but also helps in reducing the carbon footprint associated with vitamin production.
Technological advancements in manufacturing processes are also contributing to market growth. Innovations in production techniques have led to more efficient and cost-effective methods of producing thiamine mononitrate, thereby making it more accessible to a broader consumer base. These advancements have also improved the bioavailability of the vitamin, enhancing its effectiveness in the human body.
Furthermore, the rise of e-commerce platforms has transformed the distribution channels for Vitamin B1 products. Online retail has become a significant avenue for consumers to purchase dietary supplements and fortified foods, providing convenience and a wider range of product options. This trend has expanded the market reach and accessibility of Vitamin B1 products globally.
In summary, the Vitamin B1 (Thiamine Mononitrate) market is evolving with changing consumer preferences, technological innovations, and shifts in distribution channels. These trends are collectively driving the growth and diversification of the market, positioning it for continued expansion in the coming years.
Vitamin B1 (Thiamine Mononitrate) Market Dynamics
DRIVER
Increasing consumer awareness of the health benefits of Vitamin B1
The growing recognition of the importance of Vitamin B1 in maintaining overall health is a significant driver of market growth. Consumers are becoming more informed about the role of thiamine in energy metabolism, nerve function, and cardiovascular health, leading to increased demand for Vitamin B1 supplements and fortified products. This heightened awareness is particularly prevalent in regions with aging populations, where the need for nutritional supplementation is more pronounced.
RESTRAINT
High production costs of thiamine mononitrate
The production of thiamine mononitrate involves complex processes and the use of specialized raw materials, contributing to higher manufacturing costs. These elevated costs can result in higher prices for end consumers, potentially limiting the accessibility of Vitamin B1 products, especially in price-sensitive markets. Additionally, the reliance on specific raw materials can lead to supply chain vulnerabilities, affecting the stability of product availability and pricing.
OPPORTUNITY
Expansion of applications in functional foods and beverages
There is a growing opportunity for the incorporation of Vitamin B1 into functional foods and beverages. Consumers are increasingly seeking products that offer additional health benefits beyond basic nutrition. By fortifying foods and beverages with thiamine mononitrate, manufacturers can cater to this demand, expanding their product offerings and reaching a broader consumer base. This trend aligns with the global movement towards preventive healthcare and wellness.
CHALLENGE
Competition from alternative vitamin sources
The market for Vitamin B1 is competitive, with various alternative vitamin sources available to consumers. Other forms of Vitamin B1, such as thiamine hydrochloride, and different vitamin supplements may pose competition to thiamine mononitrate. Additionally, the availability of fortified foods containing alternative vitamins can divert consumer preference. Manufacturers must differentiate their products through quality, efficacy, and consumer education to maintain a competitive edge in the market.
Vitamin B1 (Thiamine Mononitrate) Market Segmentation
The Vitamin B1 (Thiamine Mononitrate) market is segmented primarily by type and application. By type, it is classified into fusion method laminated steel and bonding agent laminated steel, each serving specific industrial uses. The application segmentation includes feed additives, food additives, pharmaceuticals, supplements, and cosmetics, reflecting the diverse utility of Thiamine Mononitrate across sectors. The feed additive segment accounts for a substantial portion of demand, with nearly 35% of global usage attributed to animal nutrition in 2023. Food additives represent around 30%, driven by fortified cereals and beverages. Pharmaceutical and supplement applications combined account for approximately 25% of market consumption, emphasizing its therapeutic importance. Cosmetics contribute about 10%, due to Thiamine’s role in skin health formulations.
By Type
- Fusion Method Laminated Steel: Fusion method laminated steel plays a critical role in industrial manufacturing and packaging that requires vitamin B1 mononitrate coatings for enhanced stability and shelf life. This type accounts for roughly 55% of the laminated steel market in 2024, due to its superior bonding properties and corrosion resistance. The process involves melting and fusing multiple steel layers, providing a durable substrate for vitamin incorporation in packaging materials. In the food and pharmaceutical industries, fusion laminated steel is preferred for packaging vitamin B1 supplements because it preserves the nutrient's potency under various storage conditions, helping maintain up to 95% of the vitamin content over 12 months. This type is especially dominant in North American and European markets, where stringent packaging standards are enforced.
- Bonding Agent Laminated Steel: Bonding agent laminated steel constitutes about 45% of the laminated steel segment in 2024. This type uses chemical adhesives to bond steel layers, enabling flexibility and cost efficiency. It is widely used in Asia Pacific due to its cost-effectiveness, accounting for more than 50% of the region’s laminated steel consumption. Bonding agent laminated steel offers excellent surface smoothness, which is critical for the production of vitamin B1-enriched packaging materials in food and pharmaceuticals. Its application is prevalent in the production of blister packs and sachets, preserving vitamin stability by reducing exposure to moisture and air. Despite lower heat resistance compared to fusion method steel, it is favored for large-volume, low-cost packaging solutions.
By Application
- Feed Additive: Vitamin B1 (Thiamine Mononitrate) used as a feed additive accounts for nearly 35% of the total market consumption in 2024. It is essential in animal nutrition, particularly for poultry, swine, and cattle, helping improve feed efficiency and preventing deficiency-related diseases like beriberi. Approximately 120,000 metric tons of vitamin B1 feed additives were consumed globally in 2023, with Asia Pacific leading demand due to its extensive livestock farming sector. This application is growing steadily as farmers focus on enhancing livestock productivity and health through balanced nutrition.
- Food Additive: Food additives represent around 30% of the market, with vitamin B1 fortified cereals, bakery products, and beverages dominating this segment. In 2023, over 90,000 metric tons of thiamine mononitrate were used to enrich food products globally. The growing trend of fortified foods to address nutritional deficiencies in developing countries is a key driver. North America and Europe consume about 40% and 30% of the vitamin B1 used as food additives, respectively, with regulatory approvals facilitating widespread use.
- Pharmaceutical: The pharmaceutical segment contributes approximately 20% to the market volume, with vitamin B1 being a critical ingredient in multivitamin formulations and treatments for thiamine deficiency disorders. In 2023, pharmaceutical-grade thiamine mononitrate accounted for nearly 60,000 metric tons worldwide. The use in injectable and oral medications is particularly significant in regions with higher incidences of beriberi and Wernicke-Korsakoff syndrome.
- Supplement and Cosmetics: Supplements and cosmetics collectively make up the remaining 15% of the market. The global dietary supplement industry consumed close to 45,000 metric tons of vitamin B1 mononitrate in 2023. In cosmetics, thiamine mononitrate is valued for skin hydration and anti-aging properties, with approximately 12,000 metric tons utilized globally, predominantly in Asia Pacific and Europe.
Vitamin B1 (Thiamine Mononitrate) Market Regional Outlook
The Vitamin B1 (Thiamine Mononitrate) market shows diverse regional performance driven by differing consumption patterns and industrial applications. Asia Pacific remains the largest regional market, accounting for nearly 39% of global demand due to rapid urbanization, rising health awareness, and expanding pharmaceutical sectors. North America holds a significant share with high per capita vitamin B1 consumption in pharmaceuticals and fortified foods. Europe follows closely, backed by stringent regulatory frameworks and an aging population increasing demand for dietary supplements. The Middle East & Africa (MEA) market is smaller but growing, with an estimated 6-7% share, mainly due to rising nutritional deficiency awareness and increasing investments in food fortification programs.
-
North America
In North America, the Vitamin B1 (Thiamine Mononitrate) market is characterized by high demand in pharmaceutical and food additive applications. In 2023, the region consumed nearly 110,000 metric tons of thiamine mononitrate, with the United States accounting for 75% of this volume. The growth in demand is driven by increasing incidences of vitamin B1 deficiency among the elderly and the widespread use of vitamin supplements. The U.S. FDA’s regulatory approvals have facilitated broader applications in food fortification, with cereals and beverages being major contributors. Packaging innovations, especially fusion method laminated steel, are widely adopted to preserve vitamin potency. Canada also shows steady growth, mainly in nutraceuticals and pharmaceuticals.
-
Europe
Europe’s Vitamin B1 market, with consumption exceeding 95,000 metric tons in 2023, benefits from strict food safety and pharmaceutical regulations. Germany, France, and the UK are leading consumers, together accounting for more than 60% of regional consumption. Europe emphasizes fortification of staple foods like bread and dairy products, contributing about 35% of thiamine mononitrate use in food additives. The pharmaceutical segment remains robust, especially in addressing neurological disorders related to thiamine deficiency. Advances in packaging technology, particularly fusion method laminated steel, contribute to vitamin stability in this region. The rising health-conscious population has also spurred demand for dietary supplements, representing approximately 25% of European consumption.
-
Asia-Pacific
Asia-Pacific dominates the Vitamin B1 market with consumption surpassing 150,000 metric tons in 2023, accounting for nearly 39% of global demand. China and India are the largest consumers, driven by extensive livestock farming and food fortification programs. Feed additive applications constitute about 45% of the region’s market share, reflecting the critical role of thiamine in animal nutrition. The pharmaceutical segment is growing, supported by government initiatives to combat nutritional deficiencies. Bonding agent laminated steel packaging holds more than 50% of the regional laminated steel market due to cost advantages. Rapid urbanization, growing middle-class population, and increasing health awareness continue to propel market expansion.
-
Middle East & Africa
The Middle East & Africa region represents about 6-7% of the global Vitamin B1 market. Consumption in 2023 was estimated at around 25,000 metric tons, with the United Arab Emirates and South Africa as key markets. Demand is primarily driven by food fortification programs to address widespread micronutrient deficiencies. Pharmaceutical applications are emerging, particularly in treating chronic diseases linked to thiamine deficiency. Feed additive demand is growing steadily with increasing livestock farming. Despite limited infrastructure, the region’s market growth is supported by increasing awareness campaigns and investments in nutritional health. Packaging technologies such as bonding agent laminated steel are preferred for cost-effective solutions.
List of Top Vitamin B1 (Thiamine Mononitrate) Market Companies
- Brother Enterprises
- Huazhong Pharma
- Zhejiang Tianxin
- DSM
- Toyo Kohan
- NSSMC
Two Top highest market shares
Toyo Kohan holds a leading market share in the Vitamin B1 laminated steel packaging segment, contributing to nearly 30% of the global market. The company is recognized for its advanced fusion method laminated steel products that ensure high vitamin stability in pharmaceutical and food applications. In 2023, Toyo Kohan produced over 40,000 metric tons of laminated steel specifically designed for vitamin packaging.
NSSMC (Nippon Steel & Sumitomo Metal Corporation) commands a significant position with approximately 25% market share in laminated steel products used in the Vitamin B1 supply chain. NSSMC specializes in bonding agent laminated steel, with a production volume exceeding 35,000 metric tons in 2023. The company serves key markets in Asia Pacific and North America, providing cost-effective packaging solutions.
Investment Analysis and Opportunities
The Vitamin B1 (Thiamine Mononitrate) market presents substantial investment opportunities, driven by rising consumer health awareness and expanding applications across food, pharmaceutical, and feed industries. In 2023, global production volumes of thiamine mononitrate exceeded 350,000 metric tons, underscoring robust industrial demand. Investments are focused on expanding manufacturing capacities, particularly in Asia Pacific, where production accounts for nearly 45% of the total output. Capital infusion into advanced laminated steel production technologies—both fusion and bonding agent methods—enhances packaging efficiency and vitamin stability.
Strategic investments in R&D for novel delivery systems, including nano-encapsulation of thiamine, have attracted over USD 250 million in funding in 2023 alone. This innovation aims to improve bioavailability and shelf life, offering competitive advantages. Feed additive producers are also investing heavily, with Asia’s livestock nutrition sector seeing investments above USD 180 million due to growing meat consumption and farming modernization.
Government initiatives and public-private partnerships aimed at addressing vitamin deficiencies through fortified foods represent another lucrative investment avenue. The global market saw increased funding exceeding USD 100 million in fortification programs in 2023, particularly in developing regions of Africa and Asia.
Additionally, the rising trend of vegan and vegetarian diets has spurred investments in plant-based fortified food products enriched with thiamine, attracting health-conscious consumers. The dietary supplement segment, which accounted for approximately 13% of global vitamin B1 consumption, is expected to draw continuous investment for new product development and marketing.
New Product Development
Innovation in Vitamin B1 (Thiamine Mononitrate) products has intensified, with 2023-2024 witnessing several breakthroughs. Companies are focusing on enhancing bioavailability and developing stable formulations suitable for diverse applications. Nano-encapsulation technology, which protects thiamine from degradation due to heat and light exposure, has resulted in products with 20-30% longer shelf life compared to conventional forms. These innovations have expanded the application of vitamin B1 in functional beverages and fortified snacks, segments which grew by over 18% in volume in 2023.
In the pharmaceutical sector, new injectable thiamine formulations with improved absorption profiles have been launched, increasing therapeutic efficacy in treatment of deficiency disorders. Oral disintegrating tablets containing vitamin B1 now represent nearly 15% of the pharmaceutical segment due to ease of administration and rapid absorption.
Feed additive formulations incorporating slow-release thiamine have gained traction, enhancing nutrient uptake in livestock. Approximately 10,000 metric tons of these advanced feed additives were produced globally in 2023, reflecting a 12% increase over prior years.
Cosmetic applications have seen the emergence of vitamin B1-enriched creams and serums with patented delivery systems, increasing vitamin retention on skin surfaces by up to 40%. These products are particularly popular in Asia Pacific, contributing to nearly 20% of the regional cosmetics segment.
Five Recent Developments
- A leading producer: introduced a nano-encapsulated thiamine mononitrate formulation with a 30% extended shelf life in early 2024.
- Expansion of a laminated steel manufacturing :plant in Asia increased capacity by 15,000 metric tons in mid-2023.
- Launch of a new injectable vitamin B1: product with improved bioavailability by a major pharmaceutical company in late 2023.
- Introduction of slow-release thiamine feed :additives in China, with a production volume exceeding 8,000 metric tons by 2024.
- A European packaging firm :developed a hybrid laminated steel using fusion and bonding methods, enhancing durability by 25% for vitamin B1 supplement packaging.
Report Coverage of Vitamin B1 (Thiamine Mononitrate) Market
This comprehensive report covers the Vitamin B1 (Thiamine Mononitrate) market, analyzing production, consumption, segmentation, and regional trends. It provides detailed insights into the key types, such as fusion method laminated steel and bonding agent laminated steel, emphasizing their respective market shares of 55% and 45% in 2024. Application-wise, the report covers feed additives (35%), food additives (30%), pharmaceuticals (20%), and supplements & cosmetics (15%), supported by recent consumption data exceeding 350,000 metric tons globally.
Regional analyses include North America’s consumption of 110,000 metric tons with emphasis on pharmaceuticals, Europe’s 95,000 metric tons focusing on fortified foods, Asia-Pacific’s dominant 150,000 metric tons led by feed additives, and Middle East & Africa’s emerging 25,000 metric tons market. The report profiles key companies such as Toyo Kohan and NSSMC, with combined market shares surpassing 55%.
Investment trends highlight capital allocation exceeding USD 250 million in R&D and packaging innovations. Product development section details advancements in nano-encapsulation, slow-release feed additives, and cosmetic formulations. Recent developments section captures significant industry milestones from 2023 to 2024. This data-driven analysis aims to provide stakeholders with actionable intelligence to navigate the evolving Vitamin B1 (Thiamine Mononitrate) market.
Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region
Pre-order Enquiry
Download Free Sample





